PipelineReview.com22 小时
Denali Therapeutics Announces Primary Analysis and Long-Term Follow-Up of Phase 1/2 Study ...
SOUTH SAN FRANCISCO, CA, USA I 06, 2025 I Denali Therapeutics Inc. (NASDAQ: DNLI), today announced the primary analysis of the Phase 1/2 study in 47 ...